Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility

Public Health

Volumn 119, Issue 12, 2005, Pages 1111-1115

  Wood, E ^a,b   Kerr, T ^a   Stoltz, J ^a   Qui, Z ^a   Zhang, R ^a   Montaner, J S G ^a,b   Tyndall, M W ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood borne disease; HCV infection; Injection

Indexed keywords

HEPATITIS;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEALTH CARE FACILITY; HEPATITIS C; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INFECTION RISK; INJECTION; LOGISTIC REGRESSION ANALYSIS; MALE; NORTH AMERICA; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYRINGE;

CANADA; EPIDEMIOLOGIC STUDIES; HEPATITIS C; NEEDLE-EXCHANGE PROGRAMS; NEEDLES; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS;

HEPATITIS C VIRUS;

EID: 27944446521     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2005.05.006     Document Type: Article

References (21)

1. N. Crofts L. Nigro K. Oman E. Stevenson J. Sherman Methadone maintenance and hepatitis C virus infection among injecting drug users Addiction 92 1997 999-1005
2. D. Vlahov C.M. Fuller D.C. Ompad S. Galea D.C. Des Jarlais Updating the infection risk reduction hierarchy: Preventing transition into injection J Urban Health 81 2004 14-19
3. C.L. Miller C. Johnston PM Spittal et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users Hepatology 36 2002 737-742
4. H. Hagan H. Thiede D.C. Des Jarlais Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion Epidemiology 15 2004 543-549
5. E. Wood M.W. Tyndall PM Spittal et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme AIDS 16 2002 941-943
6. J. Kimber K. Dolan I. van Beek D. Hedrich H. Zurhold Drug consumption facilities: An update since 2000 Drug Alcohol Rev 22 2003 227-233
7. K. Dolan J. Kimber C. Fry J. Fitzgerald D. McDonald F. Frautmann Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia Drug Alcohol Rev 19 2000 337-346
8. E. Wood T. Kerr P.M. Spittal The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users J Acquir Immune Defic Syndr 32 2003 2-8
9. R.S. Broadhead T.H. Kerr J.P. G F.L. Altice Safer injection facilities in North America: Their place in public policy and health initiatives J Drug Issues 32 2002 329-355
10. W. de Jong U. Wever The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Gemany, and Switzerland Int J Drug Policy 10 1999 99-108
11. Final Report of the Evaluation of the Sydney Medically Supervised Injecting Centre. http://www.sydneymsic.com/.
12. E. Wood T. Kerr J.S. et al. Montaner Rationale for evaluating North America's first medically supervised safer injecting facility Lancet Infect Dis 4 2004 301-306
13. S.A. Strathdee D.M. Patrick S.L. Currie et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study AIDS 11 1997 F59-F65
14. E. Wood M.T. Schechter M.W. Tyndall J.S. Montaner M.V. O'Shaughnessy R.S. Hogg Antiretroviral medication use among injection drug users: Two potential futures AIDS 14 2000 1229-1235
15. E. Wood T. Kerr C. Buchner D.C. Marsh J.S. Montaner M. Tyndall Methodology for evaluating InSite: Canada's first medically supervised safer injection facility for injection drug users Harm Reduc J 1 2004 9
16. J.A. Hahn K. Page-Shafer P.J. Lum K. Ochoa A.R. Moss Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco Hepatology 34 2001 180-187
17. Wood E, Li K, Montaner JS, Schechter MT, Kerr T. Incarceration is associated with syringe sharing among injection drug users. Public Health Rep; in press.
18. E. Wood M.W. Tyndall P. Spittal et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic Int J Drug Policy 13 2002 95-102
19. PM Spittal J. Bruneau K.J. et al. Craib Surviving the sex trade: A comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs AIDS Care 15 2003 187-195
20. M.W. Tyndall S. Currie P. et al. Spittal Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic AIDS 17 2003 887-893
21. D.C. Des Jarlais D. Paone J Milliken Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial Lancet 353 1999 1657-1661